Does RhumbLine Advisers own DCPH stock?

As of its Q1 2024 13F, RhumbLine Advisers held 82,708 shares of DCPH (Deciphera Pharmaceuticals in), worth $1.3M.

How many shares of DCPH does RhumbLine Advisers own?

As of its Q1 2024 13F, RhumbLine Advisers held 82,708 shares of DCPH (Deciphera Pharmaceuticals in).

As of its Q1 2024 13F, RhumbLine Advisers' DCPH position was worth $1.3M.

RhumbLine Advisers already held DCPH in its Q4 2018 13F, the earliest on record, and listed it in 22 quarterly 13F filings.

Position history for RHUMBLINE ADVISERS's holdings in DECIPHERA PHARMACEUTICALS IN

Final Value

Final Shares

Total Value Change

-$241,000

Total Shares Change

-11,466

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q2 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2024-Q1	Increased	82,708	+2.4%	$1.3M	0.0%	—	26
2023-Q4	Decreased	80,785	-0.0%	$1.3M	0.0%	—	0
2023-Q3	Increased	80,795	+0.6%	$1M	0.0%	—	25
2023-Q2	Increased	80,336	+4.0%	$1.1M	0.0%	—	26
2023-Q1	Increased	77,256	+14.6%	$1.2M	0.0%	—	29
2022-Q4	Increased	67,426	+3.2%	$1.1M	0.0%	—	26
2022-Q3	Increased	65,356	+7.7%	$1.2M	0.0%	—	27
2022-Q2	Increased	60,668	+38.9%	$798,000	0.0%	—	33
2022-Q1	Increased	43,682	+1.0%	$405,000	0.0%	—	24
2021-Q4	Decreased	43,268	-2.3%	$423,000	0.0%	—	0
2021-Q3	Increased	44,303	+2.9%	$1.5M	0.0%	—	26
2021-Q2	Decreased	43,076	-1.6%	$1.6M	0.0%	—	0
2021-Q1	Decreased	43,754	-8.1%	$2M	0.0%	—	0
2020-Q4	Increased	47,589	+1.8%	$2.7M	0.0%	—	27
2020-Q3	Decreased	46,748	-18.4%	$2.4M	0.0%	—	0
2020-Q2	Increased	57,308	+99.0%	$3.4M	0.0%	—	43
2020-Q1	Increased	28,801	+9.8%	$1.2M	0.0%	—	28
2019-Q4	Increased	26,232	+16.6%	$1.6M	0.0%	—	30
2019-Q3	Increased	22,493	+38.4%	$763,000	0.0%	—	32
2019-Q2	Increased	16,248	+43.3%	$366,000	0.0%	—	32
2019-Q1	Decreased	11,341	-1.1%	$263,000	0.0%	—	0
2018-Q4	First report	11,466	-	$241,000	0.0%	—	0

Other major holders of DCPH: FRANKLIN TEMPLETON INC